Januvia

In the US, Januvia (sitagliptin systemic) is a member of the drug class dipeptidyl peptidase 4 inhibitors and is used to treat Diabetes, Type 2.

US matches:

• Januvia

UK matches:

• JANUVIA 100mg film-coated tablets
• JANUVIA 100mg film-coated tablets (SPC)

Ingredient matches for Januvia

Sitagliptin

Sitagliptin is reported as an ingredient of Januvia in the following countries:

• Denmark


• Slovenia

Sitagliptin phosphate (a derivative of Sitagliptin) is reported as an ingredient of Januvia in the following countries:

• Canada

Sitagliptin phosphate hydrate (a derivative of Sitagliptin) is reported as an ingredient of Januvia in the following countries:

• Aruba


• Australia


• Austria


• Bahamas


• Bahrain


• Barbados


• Belgium


• Belize


• Brazil


• Cayman Islands


• Croatia (Hrvatska)


• Dominican Republic


• France


• Germany


• Greece


• Ireland


• Italy


• Jamaica


• Mexico


• Netherlands


• Netherlands Antilles


• New Zealand


• Norway


• Peru


• Puerto Rico


• Spain


• Sweden


• Switzerland


• Trinidad & Tobago


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.